Best Grants for Rare Diseases in Guam

The FY26 Defense Established Program to Stimulate Competitive Research (DEPSCoR) aims to enhance research capabilities in eligible states by increasing the number of university researchers and institutions conducting relevant science and engineering research. Sponsored by the Department of Defense, this program will fund multiyear awards to promote research aligned with national security needs. Applications require a multi-stage submission process, emphasizing early registration and timely proposal submissions.

The US Flu Vaccine Effectiveness (VE) Network aims to enhance the effectiveness of vaccines against influenza and other respiratory pathogens, which are significant contributors to morbidity and mortality. This funding opportunity invites proposals for surveillance studies, including annual VE assessments, acute respiratory illness tracking, household transmission research, and immunogenicity studies. Applicants can apply for either Component A or B, with the option to include additional components based on their primary selection.

Research institutions and clinical centers studying asthma and other respiratory or allergic diseases in Guam can access funding through the National Institutes of Health. Grants from NIH help Guam respiratory diseases & systems programs conduct multi-center, translational research on disease mechanisms, progression, and treatment responses, including small clinical trials and immune pathway-focused projects using human materials.

Research institutions and clinical organizations conducting pediatric asthma studies can apply for NIH support to run multi-site clinical trials in Guam and other eligible U.S. locations. Grants from the National Institutes of Health help respiratory disease researchers test prevention strategies, explore new treatment targets, and use systems biology to identify asthma endotypes in economically disadvantaged urban children.

Postdoctoral fellows in the NHLBI Division of Intramural Research planning clinical research careers can receive phased support to transition to independent positions, including in Guam. Grants from the National Institutes of Health help early-career investigators move from mentored intramural work to extramural institutions, which may include rare or respiratory disease-focused programs.

NIH provides Guam medical research institutions and universities with funding for basic and early translational nonmalignant hematology studies, including respiratory and related system diseases. Grants from the U.S. Department of Health and Human Services’ National Institutes of Health support investigator-initiated R01 projects aligned with NIDDK, NIA, and NHLBI missions, with multiple application cycles through 2027.

The Gerber Foundation provides research grants focused on enhancing the health and nutrition of infants and young children, particularly those aged 0-3. The foundation seeks innovative projects that address critical health issues and improve developmental outcomes. Grants support applied research, diagnostic tools, and treatment regimens that promise significant advancements in pediatric health. Eligible applicants include tax-exempt organizations, emphasizing a commitment to projects with a direct impact on children's well-being in the U.S.

Nonprofit 501(c)(3) organizations and public institutions conducting pediatric environmental health research in Guam can apply for Gerber Foundation grants, with awards up to US $350,000. Projects must generate new, applied knowledge on environmental hazards affecting infants and young children from pre-birth to age three, such as exposure impacts or methods to lessen those exposures.

Early-career respiratory care researchers focusing on pediatric respiratory therapy can receive up to US $5,000 to support their first research projects and professional development. American Respiratory Care Foundation supports respiratory diseases and systems work in Guam and across the U.S., with funds typically used for mentoring, hands-on experience, and initial equipment or supplies.

Nonprofit organizations conducting respiratory care or cardiopulmonary research, with respiratory therapists or technicians meaningfully involved, can seek supplemental funding for original studies through the Jerome M. Sullivan Research Fund. The American Respiratory Care Foundation supports respiratory diseases and systems research in the U.S.; Guam-based projects may be eligible if they meet these criteria.

Nonprofit organizations conducting respiratory care research in Guam can seek up to US $10,000 to support projects involving respiratory therapists or technicians. The American Respiratory Care Foundation’s Parker B. Francis Respiratory Research Grant funds investigations in respiratory care and related topics, supplementing other research support for qualified physician or respiratory care practitioner principal investigators.

Graduate students and other qualified investigators conducting educational or credentialing research in respiratory care, including work on respiratory diseases and systems, can apply for support from the American Respiratory Care Foundation. With a mission to promote respiratory health, this U.S. grant offers up to US $5,000 and may benefit Guam rare disease researchers focused on lung involvement.

The Jeri Eiserman, RRT Professional Education Research Fellowship, funded by the American Respiratory Care Foundation, supports innovative research in respiratory care and airway management. This fellowship honors Jeri Eiserman's contributions to the field and includes awards for high-quality abstracts presented at the AARC Congress. Selected fellows receive a plaque, travel expenses, and registration, promoting advancements in respiratory health through research and education.

The William F. Miller, MD Postgraduate Education Recognition Award, offered by the American Respiratory Care Foundation, provides up to $5,000 to support respiratory therapists pursuing advanced degrees. Established in 1992, this award aims to foster education and professional growth in respiratory care. Recipients also receive recognition, airfare, lodging, and congress registration. Eligible applicants must meet specific educational and recommendation requirements, ensuring that deserving candidates are selected for this prestigious award.

The NBRC Gareth B. Gish Memorial Postgraduate Education Recognition Award, offered by the American Respiratory Care Foundation, honors the legacy of Gareth B. Gish, a pioneer in respiratory care. This award supports respiratory therapists pursuing advanced degrees, providing up to $5,000 in funding, along with recognition, airfare, lodging, and Congress registration. Established in 1999, it seeks to nurture future leaders in the field, continuing Mr. Gish's commitment to education and excellence in respiratory care.

The Charles D. McArthur Memorial Scholarship recognizes outstanding third and fourth-year students in accredited respiratory therapy programs. Funded by the American Respiratory Care Foundation, this award honors Charlie McArthur's legacy as a dedicated educator in respiratory care. Recipients may receive up to $1,000, including a certificate, travel, and registration for AARC Congress. Preference is given to Native American students or those from Minnesota, fostering diversity in the field of respiratory therapy.

Residents in accredited U.S. or Canadian training programs conducting basic, translational, or clinical rhinology research can apply for the ARS Resident Research Grant, which may benefit work impacting rare respiratory diseases in Guam. With a mission to advance respiratory disease research, American Rhinologic Society provides eligible investigators with up to US $10,000 for projects designed with an ARS-member faculty preceptor.

Health care professionals outside the U.S. interested in respiratory care can access an intensive observational fellowship that includes site visits and conference participation in Guam and nationwide. Grants from American Respiratory Care Foundation help respiratory and rare disease clinicians observe U.S. hospital, educational, and alternate care practices and attend the AARC Congress, with in-country expenses covered during the fellowship.

The PFF Research Fund to Cure Pulmonary Fibrosis aims to support innovative research that enhances understanding and treatment of pulmonary fibrosis. The PFF Scholars Program provides $100,000 over two years to early-stage researchers, encouraging them to pursue independent funding opportunities. Eligible applicants include post-doctoral trainees and early Assistant Professors committed to interstitial lung disease research. This initiative fosters mentorship and collaboration, ultimately advancing the field and improving patient care.

The Heiser Program for Research in Leprosy, established by Dr. Victor G. Heiser, focuses on innovative biomedical research to combat leprosy. Since 1975, it has funded over 200 grants totaling more than $20 million, supporting early-career researchers and significant projects. The program aims to enhance diagnostic tools, improve treatments, and implement effective surveillance strategies. With a dedicated Scientific Advisory Committee, it ensures rigorous proposal reviews and fosters collaboration among grantees, ultimately advancing leprosy elimination efforts.

The FSR Early Career Fellowship Grant supports early-stage researchers in sarcoidosis, fostering skills and knowledge advancement. With $150,000 over two years, this grant aims to enhance medical care and scientific understanding of the disease. Eligible applicants, including international candidates, must present innovative study proposals and demonstrate a commitment to sarcoidosis research. FSR encourages transitions from fellowships to faculty positions, thereby strengthening academic credentials and promoting impactful research contributions.

The Emerging Global Leader Award (K43) offers essential research support and protected time for early career scientists in low- and middle-income countries. This program, aligned with NIH's clinical trials policy, aims to cultivate independent research careers by providing mentorship and funding over three to five years. Eligible candidates must hold a junior faculty position at an accredited LMIC institution, fostering the growth of research capacity in their regions.

The Fogarty Emerging Global Leader Award supports early career research scientists from low- or middle-income countries (LMIC) by providing research funding and mentored career development for three to five years. This program encourages LMIC scientists in health-related fields to develop projects aligned with their country's health priorities, fostering independent research careers within their institutions. Applications are welcomed from junior faculty members, enhancing global health research and capacity in LMICs.

The Community Foundation of Shelby County

Our Mission

To inspire donor generosity and transform it into meaningful, lasting impact through charitable gifts.

Our Vision

To be the primary partner for donors who want to advance the community’s quality of life and capacity for excellence.

Heidi Norris Scholarship

Auglaize, Shelby or Mercer County residents majoring in Respiratory Therapy or a closely related field who are one year removed from high school, surpassed college freshman status and, have maintained a college GPA of not less than 2.5, and who are pursuing an Associate’s, Bachelor’s, or Master’s degree.

Selection based upon:

Financial need, academic ability, community and school service, and recommendations.

Awards

• One $1,500 scholarship

The Patient-Centered Outcomes Research Institute (PCORI) intends to release an Implementation of Findings From PCORI's Research Investments PCORI Funding Announcement (PFA) on Aug. 4, 2026, seeking to fund implementation projects that promote the uptake of peer-reviewed findings from specific PCORI-funded patient-centered comparative clinical effectiveness research (CER) in the context of the body of related evidence. This PFA is an open competition opportunity for principal investigators to propose implementation projects that move evidence toward practical use in improving health care and health outcomes. Applicants may propose projects with budgets up to $1.8 million in total direct costs.

PCORI seeks to fund implementation projects that incorporate active, multicomponent strategies that will lead to uptake and integration of evidence generated by PCORI-funded research in practice settings. Implementation should target specific end users with a clear interest in — and ability to benefit from — the evidence. Proposed implementation projects will adapt findings as needed to facilitate uptake in the proposed settings and accomplish scale-up to reach larger numbers and/or scale-out to reach broader populations and settings. Applicants must demonstrate commitment and buy-in — including from leadership as well as frontline staff critical to the success of the project — from proposed implementation sites across multiple health systems, such that they provide a supportive context and infrastructure for undertaking the proposed project. In addition, projects should involve regional and national stakeholder organizations positioned to extend uptake in broader venues.  

Applications must be guided by an established conceptual model or framework and, where possible, by evidence regarding effective strategies for implementing evidence-based practices and interventions. Additionally, applications must include a rigorous evaluation plan that documents the successful execution of the implementation approach and the impact of the project on health care and health outcomes as feasible and appropriate within the project scope.

Quality Improvement Grant Request for Proposals

Optimizing Maternal RSV Immunization Delivery: A Systems-Based Quality Improvement Initiative to Improve Uptake, Equity, and Newborn Outcomes

Pfizer, in collaboration with the Society for Maternal-Fetal Medicine (SMFM), is pleased to announce a competitive grant opportunity to support independent Quality Improvement (QI) initiatives focused on advancing maternal immunization, with a specific emphasis on Respiratory Syncytial Virus (RSV) vaccination during pregnancy.

This initiative builds upon insights generated from the Maternal Immunization Needs Assessment (MINA) project, a multi-stakeholder collaboration that identified persistent clinical, behavioral, and system-level gaps in the delivery and uptake of maternal vaccines.

We seek to fund projects that implement measurable, evidence-based interventions to improve real-world delivery of maternal RSV immunization across healthcare systems and care settings. Proposed initiatives should aim to optimize access, strengthen provider–patient communication training and tools, enhance care coordination, and address structural and behavioral barriers impacting vaccine uptake and equity.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in clinical practice or care as outlined in the specific RFP.

For all QI grants, the applicant (and ultimately the grantee) will be solely responsible for the design, implementation, and conduct of the proposed initiative. Pfizer will have no involvement in project development, execution, or outcomes.

The ARS New Investigator Research Grant aims to support innovative research in rhinology, including basic, translational, and clinical projects. The funding period is non-renewable and lasts up to 24 months. Eligible candidates include American Rhinologic Society members who have completed residency and lack significant prior funding. The number of grants awarded is contingent upon the merit of applications received, as determined by the ARS Board of Directors. This grant provides a unique opportunity for emerging researchers in the field.